4//SEC Filing
Kraws Jeffrey J 4
Accession 0001104659-26-001383
CIK 0000894158other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:53 PM ET
Size
5.7 KB
Accession
0001104659-26-001383
Insider Transaction Report
Form 4
Kraws Jeffrey J
Director
Transactions
- Award
Stock Options (right to buy)
2026-01-05+75,000→ 75,000 totalExercise: $0.24From: 2026-02-01Exp: 2033-01-04→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]These stock options vest pro rata on a monthly basis over 12 months.
Documents
Issuer
Theriva Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001380918
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:53 PM ET
- Size
- 5.7 KB